Detailed price information for Rapport Therapeutics Inc (RAPP-Q) from The Globe and Mail including charting and trades.

Continuous brain‑activity monitoring plays a key role in accurate diagnosis of seizures and epilepsy. Sponsored by Overlake ...

NeuroPace (NASDAQ:NPCE) raised its 2026 revenue outlook after reporting first-quarter results that management said reflected continued demand for its RNS System and improving commercial execution ...

My husband suffered a grand mal seizure about six months ago. He was in the hospital for seven days. When he came out of the ...

Bristol Myers Squibb's big buys: $18.1 billion in 2 biotech deals Xenon Pharmaceuticals (NASDAQ:XENE) said it is preparing to ...

Angelini Pharma is acquiring Catalyst Pharmaceuticals in a $4.1 billion transaction that expands its presence in the US rare ...

Reported positive topline data from Phase 3 X-TOLE2 study of azetukalner in FOS in March and anticipate NDA submission in Q3 2026Five additional Phase 3 studies of azetukalner continue to enroll in ep ...

Reported positive topline data from Phase 3 X-TOLE2 study of azetukalner in FOS in March and anticipate NDA submission in Q3 2026Five additional ...

Consideration is set at $31.50 per Catalyst share in cash, implying an equity value above $4.1 billion and a 21% premium to ...

My husband suffered a grand mal seizure about six months ago. He was in the hospital for seven days. When he came out of the seizure, he was very combative and experienced memory loss. He still deals ...

Most people have memory loss in the minutes before and after a generalized seizure, and they are often confused for a period ...

When a person has the type of seizure that is often shown on TV or in movies, where they have uncontrollable shaking ...